{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:08:26Z","timestamp":1783631306686,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong","doi-asserted-by":"publisher","award":["ZR2017BH037"],"award-info":[{"award-number":["ZR2017BH037"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Doctoral Foundation of Liaocheng University","award":["318051517"],"award-info":[{"award-number":["318051517"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21675071"],"award-info":[{"award-number":["21675071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402512"],"award-info":[{"award-number":["81402512"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803360"],"award-info":[{"award-number":["81803360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A Projet of Shandong Province Higher Education Science and Technology Program","award":["J13LK17"],"award-info":[{"award-number":["J13LK17"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pharep.2019.07.011","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T11:47:20Z","timestamp":1564573640000},"page":"1244-1252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Coumarin and 3,4-dihydroquinolinone derivatives: Synthesis, antidepressant activity, and molecular docking studies"],"prefix":"10.1007","volume":"71","author":[{"given":"Shi-Ben","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Shan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2019.07.011_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neubiorev.2019.04.011","article-title":"Motivation and cognitive control in depression","volume":"102","author":"Grahek","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharep.2019.07.011_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/adb.12006","article-title":"Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPAR\u03b1receptor-independent mechanism","volume":"18","author":"Bilbao","year":"2013","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharep.2019.07.011_bib0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.arabjc.2017.05.007","article-title":"Synthesis and antioxidant study of new polyphenolic hybrid-coumarins","volume":"11","author":"Pe\u00b4rez-Cruz","year":"2018","journal-title":"Arab J Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0020","article-title":"Synthesis, molecular docking studies and biological evaluation of potent coumarin\u2013carbonodithioate hybrids via microwave irradiation","author":"Mangasuli","year":"2018","journal-title":"Chem Data Collect"},{"key":"10.1016\/j.pharep.2019.07.011_bib0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bmcl.2014.11.036","article-title":"Design and synthesis of new series of coumarin\u2013aminopyran derivatives possessing potential anti-depressant-like activity","volume":"25","author":"Sashidhara","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2019.07.011_bib0030","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1016\/j.bmcl.2014.08.037","article-title":"Synthesis and evaluation of new 3-phenylcoumarin derivatives as potential antidepressant agents","volume":"24","author":"Sashidhara","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2019.07.011_bib0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2014.04.019","article-title":"Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinones caffold as a potential analgesic","volume":"79","author":"Lan","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0040","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.ejmech.2011.02.060","article-title":"Synthesis and antibacterial property of pyrrolopyrano quinolinones and pyrroloquinolines","volume":"46","author":"Jayagobi","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0045","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/S0960-894X(01)00578-9","article-title":"Design and synthesis of Pfmrk inhibitors as potential antimalarial agents","volume":"11","author":"Xiao","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2019.07.011_bib0050","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bmc.2018.02.050","article-title":"Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies","volume":"26","author":"Kumar","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2019.07.011_bib0055","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1021\/jm010978m","article-title":"3-Aryl-2-quinolone derivatives: synthesis and characterization of in vitro and in vivo antitumor effects with emphasis on a new therapeutical target connected with cell migration","volume":"45","author":"Joseph","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejmech.2014.12.004","article-title":"The chemistry and biological activity of heterocycle-fused quinolinone derivatives: a review","volume":"97","author":"Shiro","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0065","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.5012\/bkcs.2005.26.11.1757","article-title":"Synthesis of 6-alkyloxyl-3,4-dihydro-2(1H)-quinoliones and their anticonvulsant activities","volume":"26","author":"Quan","year":"2005","journal-title":"B Korean Chem Soc"},{"key":"10.1016\/j.pharep.2019.07.011_bib0070","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2174\/138955709791012247","article-title":"Biological activities of quinoline derivatives","volume":"9","author":"Kumar","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0075","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1007\/s00044-011-9922-8","article-title":"Synthesis and study of the antidepressant activity of novel 4,5-dihydro-7-alkoxy(phenoxy)-tetrazolo[1,5-a]quinoline derivatives","volume":"21","author":"Sun","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.pharep.2019.07.011_bib0080","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ejmech.2010.12.002","article-title":"Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/molecules23010153","article-title":"Novel 6- and 7-Substituted coumarins with inhibitory action against Lipoxygenase and tumor-associated carbonic anhydrase IX","volume":"23","author":"Peperidou","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.pharep.2019.07.011_bib0090","first-page":"881","article-title":"Synthesis and biological investigation of some novel sulfonamide and amide derivatives containing coumarin moieties","volume":"13","author":"Saeedi","year":"2014","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.pharep.2019.07.011_bib0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejmech.2015.10.029","article-title":"Novel oxime-bearing coumarin derivatives act as potent Nrf2\/ARE activators in vitro and in mouse model","volume":"106","author":"Chang","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejmech.2012.11.016","article-title":"Synthesis and antiproliferative activities of N-(naphthalen-2-yl)acetamide and N-(substitutedphenyl)acetamide bearing quinolin-2(1H)-one and 3,4-dihydroquinolin-2(1H)-one derivatives","volume":"59","author":"Chen","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0105","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.bmcl.2017.11.007","article-title":"Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI\/5-HT1A\/5-HT7","volume":"27","author":"Gu","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2019.07.011_bib0110","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2019.07.011_bib0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2005.02.026","article-title":"Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test","volume":"381","author":"Zomkowski","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2019.07.011_bib0120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Streu","year":"1985","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pharep.2019.07.011_bib0125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1523\/JNEUROSCI.3741-04.2005","article-title":"Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronalturnover, proliferation, and survival in the adult dentate gyrus","volume":"25","author":"Sairanen","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharep.2019.07.011_bib0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-8993(86)90075-2","article-title":"Behavioral effects of neurotensin in the open field: structure-activity studies","volume":"381","author":"Elliott","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2019.07.011_bib0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jep.2009.05.001","article-title":"Antidepressant-like effect of Lafoensia pacari A. St.-Hil. Ethanolic extract and fractions in mice","volume":"124","author":"Galdino","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharep.2019.07.011_bib0140","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1248\/bpb.29.1767","article-title":"Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models","volume":"29","author":"Sakakibara","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharep.2019.07.011_bib0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/appi.ajp.160.1.90","article-title":"Dysfunctional attitudes and 5-HT2A receptors during depression self-harm","volume":"160","author":"Meyer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2019.07.011_bib0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bmc.2017.12.016","article-title":"5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives","volume":"26","author":"Ostrowska","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2019.07.011_bib0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.compbiolchem.2018.11.015","article-title":"Molecular docking, dynamics simulations and 3D-QSAR modeling of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR agonists","volume":"78","author":"Sherin","year":"2019","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.pharep.2019.07.011_bib0165","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharep.2019.07.011_bib0170","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1359-6446(03)02827-7","article-title":"In silico prediction of blood-brain barrier permeation","volume":"8","author":"Clark","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharep.2019.07.011_bib0175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the blood-brain barrier in drug discovery and development","volume":"6","author":"Cecchelli","year":"2007","journal-title":"Nature Rev Drug Discov"},{"key":"10.1016\/j.pharep.2019.07.011_bib0180","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114019303032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114019303032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:38:11Z","timestamp":1752611891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2019.07.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1734114019303032"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2019.07.011","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin and 3,4-dihydroquinolinone derivatives: Synthesis, antidepressant activity, and molecular docking studies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2019.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}